These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36150640)

  • 1. Acetate: A therapeutic candidate against renal disorder in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    J Steroid Biochem Mol Biol; 2023 Jan; 225():106179. PubMed ID: 36150640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alleviation of adipose-hepatic glycolipid dysregulation by acetate in experimental PCOS model is associated with NF-κB/NLRP3 repression.
    Olaniyi K; Areloegbe S
    Can J Physiol Pharmacol; 2023 Dec; 101(12):630-641. PubMed ID: 37590975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE
    Life Sci; 2022 Jul; 300():120560. PubMed ID: 35452635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetate circumvents impaired metabolic switch in skeletal muscle of letrozole-induced PCOS rat model by suppression of PDK4/NLRP3.
    Olaniyi KS; Areloegbe SE
    Nutrition; 2023 Mar; 107():111914. PubMed ID: 36521396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity.
    Olaniyi KS; Areloegbe SE; Oyeleke MB
    Endocrine; 2022 Dec; 78(3):628-640. PubMed ID: 36114434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose spironolactone abates cardio-renal disorder by reduction of BAX/inflammasome expression in experimentally induced polycystic ovarian syndrome rat model.
    Peter MU; Areloegbe SE; Akintayo CO; Oniyide AA; Aturamu A; Olaniyi KS
    Can J Physiol Pharmacol; 2022 Sep; 100(9):890-902. PubMed ID: 35771488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short chain fatty acid, acetate restores ovarian function in experimentally induced PCOS rat model.
    Olaniyi KS; Bashir AM; Areloegbe SE; Sabinari IW; Akintayo CO; Oniyide AA; Aturamu A
    PLoS One; 2022; 17(7):e0272124. PubMed ID: 35881588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective Role of Acetate Against Depressive-Like Behaviour Associated with Letrozole-Induced PCOS Rat Model: Involvement of HDAC2 and DNA Methylation.
    Wolugbom JA; Areloegbe SE; Olaniyi KS
    Mol Neurobiol; 2023 Jan; 60(1):355-368. PubMed ID: 36269541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model.
    Areloegbe SE; Peter MU; Oyeleke MB; Olaniyi KS
    BMC Endocr Disord; 2022 Sep; 22(1):224. PubMed ID: 36071485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrate alleviates renal inflammation and fibrosis in a rat model of polycystic ovarian syndrome by suppression of SDF-1.
    Bashir AM; Olaniyi KS
    BMC Pharmacol Toxicol; 2023 Oct; 24(1):48. PubMed ID: 37789355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetate ameliorates ovarian mitochondrial dysfunction in letrozole-induced polycystic ovarian syndrome rat model by improving mitofusin-2.
    Olaniyi KS; Areloegbe SE
    J Physiol Sci; 2024 Apr; 74(1):22. PubMed ID: 38561673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1.
    Areloegbe SE; Olaniyi KS
    Biochem Biophys Res Commun; 2023 Nov; 681():62-72. PubMed ID: 37757668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac energy depletion in a rat model of polycystic ovarian syndrome is reversed by acetate and associated with inhibitory effect of HDAC2/mTOR.
    Olaniyi KS; Areloegbe SE; Fiemotongha FE
    Eur J Pharmacol; 2024 Jan; 962():176243. PubMed ID: 38048978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue.
    Rabah HM; Mohamed DA; Mariah RA; Abd El-Khalik SR; Khattab HA; AbuoHashish NA; Abdelsattar AM; Raslan MA; Farghal EE; Eltokhy AK
    Redox Rep; 2023 Dec; 28(1):2160569. PubMed ID: 36661246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of FoxO1 alleviates polycystic ovarian syndrome by reducing inflammation and the immune response.
    Huang X; Luo X; Huang S; Chen X; Qiu L
    Funct Integr Genomics; 2024 Jan; 24(1):6. PubMed ID: 38189995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
    Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
    Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine anomalies in cell proliferation, energy homeostasis and oxidative stress in PCOS hamsters, M. auratus: Therapeutic potentials of melatonin.
    Hansda SR; Haldar C
    Life Sci; 2021 Sep; 281():119755. PubMed ID: 34175318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome.
    Olaniyi KS; Areloegbe SE; Areola ED; Sabinari IW; Fafure AA; Agbana RD; Atuma CL; Shah MZUH; Ajadi IO; Olatunji LA
    Toxicol Appl Pharmacol; 2023 Aug; 473():116604. PubMed ID: 37328115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Metformin on Reproductive, Endocrine, and Metabolic Characteristics of Female Offspring in a Rat Model of Letrozole-Induced Polycystic Ovarian Syndrome With Insulin Resistance.
    Xie Y; Xiao L; Li S
    Front Endocrinol (Lausanne); 2021; 12():701590. PubMed ID: 34484117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partially purified non-polar phytocomponents from Aloe barbadensis Mill. gel restores metabolic and reproductive comorbidities in letrozole-induced polycystic ovary syndrome rodent model- an "in-vivo" study.
    Dey A; Dhadhal S; Maharjan R; Nagar PS; Nampoothiri L
    J Ethnopharmacol; 2022 Jun; 291():115161. PubMed ID: 35271948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.